Table of Content

1 Nonalcoholic Steatohepatitis Treatment Market Overview
1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis Treatment
1.2 Nonalcoholic Steatohepatitis Treatment Segment by Type
1.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034)
1.2.2 Solid
1.2.3 Liquid
1.3 Nonalcoholic Steatohepatitis Treatment Segment by Application
1.3.1 Global Nonalcoholic Steatohepatitis Treatment Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Specialized Clinic
1.3.5 Hospital Pharmacy
1.3.6 Drug Store
1.3.7 Mail Order Pharmacy
1.4 Global Nonalcoholic Steatohepatitis Treatment Market Size Estimates and Forecasts
1.4.1 Global Nonalcoholic Steatohepatitis Treatment Revenue 2018-2034
1.4.2 Global Nonalcoholic Steatohepatitis Treatment Sales 2018-2034
1.4.3 Global Nonalcoholic Steatohepatitis Treatment Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Nonalcoholic Steatohepatitis Treatment Market Competition by Manufacturers
2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nonalcoholic Steatohepatitis Treatment Average Price by Manufacturers (2018-2024)
2.4 Global Nonalcoholic Steatohepatitis Treatment Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Product Type & Application
2.7 Nonalcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
2.7.1 Nonalcoholic Steatohepatitis Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue
2.7.3 Global Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nonalcoholic Steatohepatitis Treatment Retrospective Market Scenario by Region
3.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Nonalcoholic Steatohepatitis Treatment Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2018-2034
3.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2018-2024
3.2.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2024-2034
3.3 Global Nonalcoholic Steatohepatitis Treatment Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2018-2034
3.3.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2018-2024
3.3.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2024-2034
3.4 North America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.4.1 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2034)
3.4.3 North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.5.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2034)
3.5.3 Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2034)
3.6.3 Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.7.1 Latin America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2034)
3.7.3 Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2034)
3.8.3 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2018-2034)
4.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2018-2024)
4.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2034)
4.1.3 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2018-2034)
4.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2018-2034)
4.2.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2018-2024)
4.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2024-2034)
4.2.3 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2034)
4.3 Global Nonalcoholic Steatohepatitis Treatment Price by Type (2018-2034)
5 Segment by Application
5.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2018-2034)
5.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2018-2024)
5.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2034)
5.1.3 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2018-2034)
5.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2018-2034)
5.2.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2018-2024)
5.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2024-2034)
5.2.3 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2034)
5.3 Global Nonalcoholic Steatohepatitis Treatment Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Arena Pharmaceuticals
6.2.1 Arena Pharmaceuticals Corporation Information
6.2.2 Arena Pharmaceuticals Description and Business Overview
6.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.2.5 Arena Pharmaceuticals Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Vivus
6.6.1 Vivus Corporation Information
6.6.2 Vivus Description and Business Overview
6.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.6.5 Vivus Recent Developments/Updates
6.7 Arisaph Pharmaceuticals
6.6.1 Arisaph Pharmaceuticals Corporation Information
6.6.2 Arisaph Pharmaceuticals Description and Business Overview
6.6.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.7.5 Arisaph Pharmaceuticals Recent Developments/Updates
6.8 Cempra Pharmaceuticals
6.8.1 Cempra Pharmaceuticals Corporation Information
6.8.2 Cempra Pharmaceuticals Description and Business Overview
6.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.8.5 Cempra Pharmaceuticals Recent Developments/Updates
6.9 Galectin Therapeutics
6.9.1 Galectin Therapeutics Corporation Information
6.9.2 Galectin Therapeutics Description and Business Overview
6.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.9.5 Galectin Therapeutics Recent Developments/Updates
6.10 Galmed Pharmaceuticals
6.10.1 Galmed Pharmaceuticals Corporation Information
6.10.2 Galmed Pharmaceuticals Description and Business Overview
6.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.10.5 Galmed Pharmaceuticals Recent Developments/Updates
6.11 Genfit
6.11.1 Genfit Corporation Information
6.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Description and Business Overview
6.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.11.5 Genfit Recent Developments/Updates
6.12 Gilead
6.12.1 Gilead Corporation Information
6.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Description and Business Overview
6.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.12.5 Gilead Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nonalcoholic Steatohepatitis Treatment Industry Chain Analysis
7.2 Nonalcoholic Steatohepatitis Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nonalcoholic Steatohepatitis Treatment Production Mode & Process
7.4 Nonalcoholic Steatohepatitis Treatment Sales and Marketing
7.4.1 Nonalcoholic Steatohepatitis Treatment Sales Channels
7.4.2 Nonalcoholic Steatohepatitis Treatment Distributors
7.5 Nonalcoholic Steatohepatitis Treatment Customers
8 Nonalcoholic Steatohepatitis Treatment Market Dynamics
8.1 Nonalcoholic Steatohepatitis Treatment Industry Trends
8.2 Nonalcoholic Steatohepatitis Treatment Market Drivers
8.3 Nonalcoholic Steatohepatitis Treatment Market Challenges
8.4 Nonalcoholic Steatohepatitis Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nonalcoholic Steatohepatitis Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2018-2024) & (K Units)
Table 18. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2018-2024)
Table 19. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (K Units)
Table 20. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2024-2034)
Table 21. Global Nonalcoholic Steatohepatitis Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2018-2024)
Table 23. Global Nonalcoholic Steatohepatitis Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2024-2034)
Table 25. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 27. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 28. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 33. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2018-2024)
Table 51. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2034)
Table 52. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2018-2024)
Table 53. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2024-2034)
Table 54. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2024)
Table 57. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2024-2034)
Table 58. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2024-2034)
Table 60. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2018-2024)
Table 61. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2024-2034)
Table 62. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2018-2024)
Table 63. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2024-2034)
Table 64. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2024)
Table 67. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2024-2034)
Table 68. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2024-2034)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Arena Pharmaceuticals Corporation Information
Table 76. Arena Pharmaceuticals Description and Business Overview
Table 77. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 79. Arena Pharmaceuticals Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GSK Nonalcoholic Steatohepatitis Treatment Product
Table 84. GSK Recent Developments/Updates
Table 85. Novo Nordisk Corporation Information
Table 86. Novo Nordisk Description and Business Overview
Table 87. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product
Table 89. Novo Nordisk Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Roche Nonalcoholic Steatohepatitis Treatment Product
Table 94. Roche Recent Developments/Updates
Table 95. Vivus Corporation Information
Table 96. Vivus Description and Business Overview
Table 97. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Vivus Nonalcoholic Steatohepatitis Treatment Product
Table 99. Vivus Recent Developments/Updates
Table 100. Arisaph Pharmaceuticals Corporation Information
Table 101. Arisaph Pharmaceuticals Description and Business Overview
Table 102. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 104. Arisaph Pharmaceuticals Recent Developments/Updates
Table 105. Cempra Pharmaceuticals Corporation Information
Table 106. Cempra Pharmaceuticals Description and Business Overview
Table 107. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 109. Cempra Pharmaceuticals Recent Developments/Updates
Table 110. Galectin Therapeutics Corporation Information
Table 111. Galectin Therapeutics Description and Business Overview
Table 112. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product
Table 114. Galectin Therapeutics Recent Developments/Updates
Table 115. Galmed Pharmaceuticals Corporation Information
Table 116. Galmed Pharmaceuticals Description and Business Overview
Table 117. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 119. Galmed Pharmaceuticals Recent Developments/Updates
Table 120. Genfit Corporation Information
Table 121. Genfit Description and Business Overview
Table 122. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Genfit Nonalcoholic Steatohepatitis Treatment Product
Table 124. Genfit Recent Developments/Updates
Table 125. Gilead Corporation Information
Table 126. Gilead Description and Business Overview
Table 127. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Gilead Nonalcoholic Steatohepatitis Treatment Product
Table 129. Gilead Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Nonalcoholic Steatohepatitis Treatment Distributors List
Table 133. Nonalcoholic Steatohepatitis Treatment Customers List
Table 134. Nonalcoholic Steatohepatitis Treatment Market Trends
Table 135. Nonalcoholic Steatohepatitis Treatment Market Drivers
Table 136. Nonalcoholic Steatohepatitis Treatment Market Challenges
Table 137. Nonalcoholic Steatohepatitis Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nonalcoholic Steatohepatitis Treatment
Figure 2. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Share by Type in 2022 & 2034
Figure 4. Solid Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Nonalcoholic Steatohepatitis Treatment Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Diagnostic Center
Figure 10. Specialized Clinic
Figure 11. Hospital Pharmacy
Figure 12. Drug Store
Figure 13. Mail Order Pharmacy
Figure 14. Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Nonalcoholic Steatohepatitis Treatment Market Size (2018-2034) & (US$ Million)
Figure 16. Global Nonalcoholic Steatohepatitis Treatment Sales (2018-2034) & (K Units)
Figure 17. Global Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) & (2018-2034)
Figure 18. Nonalcoholic Steatohepatitis Treatment Report Years Considered
Figure 19. Nonalcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2022
Figure 20. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Nonalcoholic Steatohepatitis Treatment Players: Market Share by Revenue in 2022
Figure 22. Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2034)
Figure 25. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2034)
Figure 26. United States Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2034)
Figure 29. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2034)
Figure 30. Germany Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2018-2034)
Figure 37. China Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Taiwan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2034)
Figure 47. Latin America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. UAE Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Type (2018-2034)
Figure 57. Global Revenue Market Share of Nonalcoholic Steatohepatitis Treatment by Type (2018-2034)
Figure 58. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Application (2018-2034)
Figure 60. Global Revenue Market Share of Nonalcoholic Steatohepatitis Treatment by Application (2018-2034)
Figure 61. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2018-2034)
Figure 62. Nonalcoholic Steatohepatitis Treatment Value Chain
Figure 63. Nonalcoholic Steatohepatitis Treatment Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed